Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4162640
Max Phase: Preclinical
Molecular Formula: C10H18Cl2N8
Molecular Weight: 248.29
Molecule Type: Small molecule
Associated Items:
ID: ALA4162640
Max Phase: Preclinical
Molecular Formula: C10H18Cl2N8
Molecular Weight: 248.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.N=C(N)/N=C(\N)N1CCN(c2ncccn2)CC1
Standard InChI: InChI=1S/C10H16N8.2ClH/c11-8(12)16-9(13)17-4-6-18(7-5-17)10-14-2-1-3-15-10;;/h1-3H,4-7H2,(H5,11,12,13,16);2*1H
Standard InChI Key: HWFNNZRBTGBIEH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 248.29 | Molecular Weight (Monoisotopic): 248.1498 | AlogP: -1.19 | #Rotatable Bonds: 1 |
Polar Surface Area: 120.51 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 11.88 | CX LogP: -0.86 | CX LogD: -3.16 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.42 | Np Likeness Score: -1.33 |
1. Guariento S, Tonelli M, Espinoza S, Gerasimov AS, Gainetdinov RR, Cichero E.. (2018) Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists., 146 [PMID:29407948] [10.1016/j.ejmech.2018.01.059] |
Source(1):